SDS Optic AAQS

Mitä SDS Optic tekee? SDS Optic SA generates revenue by developing biochemistry, engineering, and fiber optic technology solutions specifically designed for cancer diagnosis and treatment. The company focuses its primary research activities on the oncology sector, aiming to improve upon current diagnostic methods that rely on biopsy and histopathology. By implementing the InProbe method, the firm offers a faster and more accurate alternative capable of providing results within 20 minutes to identify cancer markers. The company also conducts research into other diseases, such as fungal diseases, and collaborates with specialists from diverse fields including biology, medicine, technology, and sciences related to medicine. These partnerships support the development of advanced diagnostic tools, positioning the firm to serve the medical and scientific communities seeking improved early detection methods, particularly for breast cancer. SDS Optic on yksi Eurpooliin suosituimmista yhtiöistä.